Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Aleafia Health Inc    ALEF   CA01444Q1046

ALEAFIA HEALTH INC

(ALEF)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Aleafia Health Secures Health Canada Licence Amendment for Entire 1.1M sq. ft. Port Perry Outdoor Cultivation Facility

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/15/2019 | 07:01am EDT

TORONTO, July 15, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to announce that on July 12, 2019, Aleafia Health’s wholly-owned subsidiary, Aleafia Farms Inc., secured a License Amendment (the “Licence”) under Health Canada’s Cannabis Regulations authorizing cannabis cultivation for the entirety of the Company’s Port Perry Outdoor Grow facility. The Licence immediately increases the Company’s licensed and operational outdoor cultivation area from 292,000 sq. ft. to over 1.1 million sq. ft.

As previously announced on June 10, 2019, Aleafia Farms received approval for cultivation in Zone 1 of the Outdoor Grow facility, and days later completed the planting of Canada’s first legal, large-scale outdoor crop. The License now adds Zones 2, 3 and 4 which encompasses the full 1.1 million sq. ft. cultivation area. The License is effective as of July 12, 2019 and expires on October 13, 2020.

The Company expects to commence planting the newly licensed area on July 15, 2019, using approximately 7,000 cannabis plants currently growing in pots in Zone 1. The Outdoor Grow operation will be overseen by Aleafia Health’s proven, experienced cultivation team, which together have led the build-out and operations of seven cannabis cultivation facilities.

“The immediate four-fold increase in Aleafia Health’s licensed and operational cultivation area is our most significant milestone to date,” said Aleafia Health Chairman Julian Fantino. “We will continue to lead the way in low-cost production. This exponentially increases our total cultivation footprint while securing and increasing product supply for medical cannabis patients.”

It is intended that the cannabis grown at the Company’s Outdoor Grow facility will be processed at the Company’s Paris Facility, for the extraction and production of high-margin products within a closed loop ecosystem.

“Our team is again relentlessly focused on execution, with plants in the ground within one business day of receiving our new Health Canada licence,” said Aleafia Health CEO Geoffrey Benic. “We plan to benefit from the increasing scale of our production operations across three facilities. Low-cost cannabis grown at Port Perry will accelerate and scale our mission of growing, producing and selling high-margin value-added cannabis health and wellness products globally.”

For Investor and Media Relations, please contact:

Nicholas Bergamini, VP Investor Relations
416-860-5665
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a leading, vertically integrated cannabis health and wellness company with four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements.

Aleafia Health through its subsidiaries owns three major cannabis product & cultivation facilities, two of which are licensed and operational. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators.

Aleafia Health maintains a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and treatment best practices. The Company is committed to creating sustainable shareholder value and has been named the 2019 top performing company of the year by the TSX Venture Exchange prior to graduation to the TSX.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aleafia Health or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b7ee0d2b-dc72-4e87-84ff-4a1d88782fbf

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.

Primary Logo

Aleafia Health - Port Perry Outdoor Cultivation

A small number of the 7,000 cannabis plants growing in pots which will be transferred to the newly licensed cultivation area.

© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALEAFIA HEALTH INC
08/19ALEAFIA HEALTH : TransCanna Announces Appointment of Mr. Ian Klassen to Board of..
AQ
08/14Aleafia Health Reports Record Revenue in Q2 2019, 159% Q/Q Revenue Increase
GL
08/07Aleafia Health to Announce 2019 Second Quarter Financial Results
GL
08/01Aleafia Health Completes Largest Cannabis Order to Date, Provides Facility Up..
GL
07/15Aleafia Health Secures Health Canada Licence Amendment for Entire 1.1M sq. ft..
GL
07/12YIELD GROWTH Announces Definitive Agreement for Exclusive Distribution of Urb..
AQ
07/11Aleafia Health Added to NYSE-Listed The Cannabis ETF
GL
07/02Aleafia Health Secures Health Canada Permits to Export Cannabis Products to A..
GL
06/27ALEAFIA HEALTH : IIROC Trade Resumption - ALEF.DB
AQ
06/27ALEAFIA HEALTH : IIROC Trade Resumption - ALEF.WT
AQ
More news
Financials (CAD)
Sales 2019 16,2 M
EBIT 2019 -30,6 M
Net income 2019 -54,5 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020 -
Capi. / Sales2019 18,5x
Capi. / Sales2020 1,85x
Capitalization 299 M
Chart ALEAFIA HEALTH INC
Duration : Period :
Aleafia Health Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALEAFIA HEALTH INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 3,00  CAD
Last Close Price 1,09  CAD
Spread / Highest target 175%
Spread / Average Target 175%
Spread / Lowest Target 175%
EPS Revisions
Managers
NameTitle
Geoffrey M. Benic Chief Executive Officer
Julian Fantino Executive Chairman
Benjamin Ferdinand Chief Financial Officer
Gary Goodyear Director & President-Clinic Operations
Michael Verbora Director & Chief Medical Officer